Y-mAbs Announces Data to be Presented at 2019 ASCO Annual Meeting

World News: . []

NEW YORK May 15 2019 GLOBE NEWSWIRE -- Y-mAbs Therapeutics Inc the LINK  or Y-mAbs Nasdaq YMAB a late-stage LINK  biopharmaceutical company focused on the development and commercialization of novel antibody-based ther apeutic...

More news and information about Y-mAbs Therapeutics, Inc

Published By:

Globe Newswire: 22:00 GMT Wednesday 15th May 2019

Published: .

Search for other references to "mabs" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us